United States Enoxaparin Market Report 2016

October 2016 | 123 pages | ID: U05524FF3E2EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Enoxaparin

Revenue, means the sales value of Enoxaparin

This report studies sales (consumption) of Enoxaparin in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer, Inc. (US)
• Bayer Healthcare AG (Germany)
• GlaxoSmithKline Plc. (UK)
• Boehringer Ingelheim (Germany)
• Sanofi S.A. (France)
• Abbott India Limited (India)
• Aspen Holdings (South Africa)
• Bristol-Myers Squibb Company (US)
• Eisai Inc. (US)
• Mitsubishi Tanabe Pharma Corporation (Japan)
• Teva Pharmaceutical Industries Ltd. (Israel)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Enoxaparin in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Enoxaparin Market Report 2016

1 ENOXAPARIN OVERVIEW

1.1 Product Overview and Scope of Enoxaparin
1.2 Classification of Enoxaparin
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Enoxaparin
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Enoxaparin (2011-2021)
  1.4.1 United States Enoxaparin Sales and Growth Rate (2011-2021)
  1.4.2 United States Enoxaparin Revenue and Growth Rate (2011-2021)

2 UNITED STATES ENOXAPARIN COMPETITION BY MANUFACTURERS

2.1 United States Enoxaparin Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Enoxaparin Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Enoxaparin Average Price by Manufactures (2015 and 2016)
2.4 Enoxaparin Market Competitive Situation and Trends
  2.4.1 Enoxaparin Market Concentration Rate
  2.4.2 Enoxaparin Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ENOXAPARIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Enoxaparin Sales and Market Share by Type (2011-2016)
3.2 United States Enoxaparin Revenue and Market Share by Type (2011-2016)
3.3 United States Enoxaparin Price by Type (2011-2016)
3.4 United States Enoxaparin Sales Growth Rate by Type (2011-2016)

4 UNITED STATES ENOXAPARIN SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Enoxaparin Sales and Market Share by Application (2011-2016)
4.2 United States Enoxaparin Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES ENOXAPARIN MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Enoxaparin Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer, Inc. (US) Enoxaparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Bayer Healthcare AG (Germany)
  5.2.2 Enoxaparin Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Bayer Healthcare AG (Germany) Enoxaparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc. (UK)
  5.3.2 Enoxaparin Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 GlaxoSmithKline Plc. (UK) Enoxaparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Boehringer Ingelheim (Germany)
  5.4.2 Enoxaparin Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Boehringer Ingelheim (Germany) Enoxaparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Sanofi S.A. (France)
  5.5.2 Enoxaparin Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Sanofi S.A. (France) Enoxaparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Abbott India Limited (India)
  5.6.2 Enoxaparin Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Abbott India Limited (India) Enoxaparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Aspen Holdings (South Africa)
  5.7.2 Enoxaparin Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Aspen Holdings (South Africa) Enoxaparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Bristol-Myers Squibb Company (US)
  5.8.2 Enoxaparin Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Bristol-Myers Squibb Company (US) Enoxaparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Eisai Inc. (US)
  5.9.2 Enoxaparin Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Eisai Inc. (US) Enoxaparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Mitsubishi Tanabe Pharma Corporation (Japan)
  5.10.2 Enoxaparin Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Enoxaparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Teva Pharmaceutical Industries Ltd. (Israel)

6 ENOXAPARIN MANUFACTURING COST ANALYSIS

6.1 Enoxaparin Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Enoxaparin

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Enoxaparin Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Enoxaparin Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES ENOXAPARIN MARKET FORECAST (2016-2021)

10.1 United States Enoxaparin Sales, Revenue Forecast (2016-2021)
10.2 United States Enoxaparin Sales Forecast by Type (2016-2021)
10.3 United States Enoxaparin Sales Forecast by Application (2016-2021)
10.4 Enoxaparin Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Enoxaparin
Table Classification of Enoxaparin
Figure United States Sales Market Share of Enoxaparin by Type in 2015
Table Application of Enoxaparin
Figure United States Sales Market Share of Enoxaparin by Application in 2015
Figure United States Enoxaparin Sales and Growth Rate (2011-2021)
Figure United States Enoxaparin Revenue and Growth Rate (2011-2021)
Table United States Enoxaparin Sales of Key Manufacturers (2015 and 2016)
Table United States Enoxaparin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Enoxaparin Sales Share by Manufacturers
Figure 2016 Enoxaparin Sales Share by Manufacturers
Table United States Enoxaparin Revenue by Manufacturers (2015 and 2016)
Table United States Enoxaparin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Enoxaparin Revenue Share by Manufacturers
Table 2016 United States Enoxaparin Revenue Share by Manufacturers
Table United States Market Enoxaparin Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Enoxaparin Average Price of Key Manufacturers in 2015
Figure Enoxaparin Market Share of Top 3 Manufacturers
Figure Enoxaparin Market Share of Top 5 Manufacturers
Table United States Enoxaparin Sales by Type (2011-2016)
Table United States Enoxaparin Sales Share by Type (2011-2016)
Figure United States Enoxaparin Sales Market Share by Type in 2015
Table United States Enoxaparin Revenue and Market Share by Type (2011-2016)
Table United States Enoxaparin Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Enoxaparin by Type (2011-2016)
Table United States Enoxaparin Price by Type (2011-2016)
Figure United States Enoxaparin Sales Growth Rate by Type (2011-2016)
Table United States Enoxaparin Sales by Application (2011-2016)
Table United States Enoxaparin Sales Market Share by Application (2011-2016)
Figure United States Enoxaparin Sales Market Share by Application in 2015
Table United States Enoxaparin Sales Growth Rate by Application (2011-2016)
Figure United States Enoxaparin Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Enoxaparin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Enoxaparin Sales Market Share (2011-2016)
Table Bayer Healthcare AG (Germany) Basic Information List
Table Bayer Healthcare AG (Germany) Enoxaparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Healthcare AG (Germany) Enoxaparin Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Enoxaparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Enoxaparin Sales Market Share (2011-2016)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Enoxaparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim (Germany) Enoxaparin Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Enoxaparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Enoxaparin Sales Market Share (2011-2016)
Table Abbott India Limited (India) Basic Information List
Table Abbott India Limited (India) Enoxaparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott India Limited (India) Enoxaparin Sales Market Share (2011-2016)
Table Aspen Holdings (South Africa) Basic Information List
Table Aspen Holdings (South Africa) Enoxaparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aspen Holdings (South Africa) Enoxaparin Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Enoxaparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (US) Enoxaparin Sales Market Share (2011-2016)
Table Eisai Inc. (US) Basic Information List
Table Eisai Inc. (US) Enoxaparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Inc. (US) Enoxaparin Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table Mitsubishi Tanabe Pharma Corporation (Japan) Enoxaparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Enoxaparin Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List
Table Teva Pharmaceutical Industries Ltd. (Israel) Enoxaparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Enoxaparin Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Enoxaparin
Figure Manufacturing Process Analysis of Enoxaparin
Figure Enoxaparin Industrial Chain Analysis
Table Raw Materials Sources of Enoxaparin Major Manufacturers in 2015
Table Major Buyers of Enoxaparin
Table Distributors/Traders List
Figure United States Enoxaparin Production and Growth Rate Forecast (2016-2021)
Figure United States Enoxaparin Revenue and Growth Rate Forecast (2016-2021)
Table United States Enoxaparin Production Forecast by Type (2016-2021)
Table United States Enoxaparin Consumption Forecast by Application (2016-2021)